(19)
(11)
EP 1 044 267 A2
(12)
(88)
Date of publication A3:
10.09.1999
(43)
Date of publication:
18.10.2000
Bulletin 2000/42
(21)
Application number:
98966103.8
(22)
Date of filing:
28.12.1998
(51)
International Patent Classification (IPC)
7
:
C12N
15/12
,
C12N
15/62
,
C12N
5/10
,
C12N
1/21
,
C12N
1/19
,
C07K
14/705
,
C07K
16/28
,
A61K
38/17
,
A61K
39/395
,
G01N
33/53
,
G01N
33/68
(86)
International application number:
PCT/US9827/688
(87)
International publication number:
WO 9933/967
(
08.07.1999
Gazette 1999/27)
(84)
Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
(30)
Priority:
29.12.1997
US 68925 P
(71)
Applicant:
REGENERON PHARMACEUTICALS, INC.
Tarrytown, NY 10591-6707 (US)
(72)
Inventor:
VALENZUELA, David, M.
Yorktown Heights, NY 10598 (US)
(74)
Representative:
Goldin, Douglas Michael et al
J.A. KEMP & CO.14 South SquareGray's Inn
London WC1R 5LX
London WC1R 5LX (GB)
(54)
NOVEL NUCLEIC ACID AND POLYPEPTIDE WITH HOMOLOGY TO THE TNF-RECEPTORS